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Abstract
The Peutz-Jeghers syndrome (PJS) is an autosomal-dominant hamartomatous polyposis syndrome characterized
by mucocutaneous pigmentation, gastrointestinal polyps and the increased risk of multiple cancers. The causative
point mutation in the STK11 gene of most patients accounts for about 30% of the cases of partial and complete gene
deletion. This is a report on a girl with PJS features, learning difficulties, dysmorphic features and cardiac malforma-
tion, bearing a de novo 1.1 Mb deletion at 19p13.3. This deletion encompasses at least 47 genes, including STK11.
This is the first report on 19p13.3 deletion associated with a PJS phenotype, as well as other atypical manifestations,
thereby implying a new contiguous gene syndrome.
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The Peutz-Jeghers syndrome (PJS) is a rare auto-
somal-dominant disease characterized by gastrointestinal
polyposis and mucocutaneous pigmentation. It is associ-
ated with a predisposition for various types of benign and
malignant gastrointestinal and extra-intestinal tumors
(Giardiello and Trimbath, 2006). In 1998, point mutations
in the STK11(LKB1) gene were described as inducing PJS
(Hemminki et al., 1998; Jenne et al., 1998). STK11,
mapped at 19p13.3, encodes a serine-threonine protein
kinase that acts as a regulator of cell-cycle metabolism and
cell polarity, with evidence of tumor suppressor functions
(Forcet et al., 2005).
Germline point mutations in STK11 have been identi-
fied in most patients with PJS, with partial or whole gene
deletion in approximately 30% of these (Aretz et al., 2005;
Resta et al., 2010). Some PJS individuals with deletions of
up to 250 kb, encompassing STK11 and neighboring genes,
have been described (Le Meur et al., 2004; Resta et al.,
2010). Only one patient with a large deletion, between
220-250 kb, presented other features in addition to PJS
characteristics,namelylearningdisabilityandscoliosis(Le
Meur et al., 2004). Carriers of larger deletions at 19p13.3,
but without PJS features, have been reported (Archer et al.,
2005; Hurgoiu and Suciu, 1984). Here, a patient with PJS,
as well as other atypical clinical manifestations due to a
~1.1 Mb deletion at 19p13.3, is described.
The patient, a girl, was the second child of a non-con-
sanguineous and healthy couple. The father was 30-years-
old, and the mother 28, at the time of birth. The first child,
anapparentlynormalboyatbirth,wasstillbornafteracom-
plicated delivery. The girl was delivered at term, by caesar-
ean section, after an uncomplicated pregnancy. Birth
weight was 2500 g, body length 44 cm, and Apgar scores 3
and 5. For the first 18 days, she required intensive care-unit
intervention with supplemental oxygen. At five days of
age, atrial and ventricular septal defects were diagnosed,
which were surgically corrected at 10 months. Hypotonia
was noted in the first year of life. She had a seizure at five
years-old, without recurrence. She started walking at age
five, when she also developed diurnal sphincter control.
The onset of menarche occurred at 13, followed by normal
menstrual periods. At 14, learning disability was apparent,
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centile) and head circumference 54 cm (50
th centile). High
myopiaof-13dioptersaffectedbotheyes.Dysmorphicfea-
tures included epicanthic folds, high nasal bridge, mild
kyphoscoliosis, cubitus valgus and a wide gap between the
1st and 2nd toes. Black pigment spots were noted on the
eyelids, nose, cheeks and lips (Figure 1).
At 14 years-old, medical evaluation included normal
karyotype, renal ultrasound, magnetic resonance-imaging
of the brain, electroencephalogram and electroneuromyo-
graphy and colonoscopy. Vertebral column radiography
documented mild kyphoscoliosis and hyperlordosis. Poly-
somnography revealed 63 apneic episodes.
Microarray-based comparative genomic hybridiza-
tion (array CGH) was initially carried out with DNA ex-
tracted from the peripheral blood of the patient and her
parents, using a bacterial artificial chromosome (BAC)
microarray (the SignatureChip Whole Genome; Signature
Genomic Laboratories, Spokane, WA), as previously de-
scribed(Ballifetal.,2008).Theextentofdeletioninthepa-
tient was more precisely defined using a 135K-feature
oligonucleotide-based microarray (SignatureChip Oligo
SolutionTM, version 2.0, designed by Signature Genomics
andmanufacturedbyRocheNimblegen,Madison,WI),ac-
cording to previously described methods (Duker et al.,
2010). Fluorescence in situ hybridization (FISH) was with
metaphase cells from the patient and her parents, using
BAC clone CTD-2589F14 from 19p13.3, according to
Traylor et al. (2009). Interphase FISH using BAC clone
CTD-2086M18 from 3q29 was also carried out on the pa-
tient, according to Ballif et al. (2008).
Oligonucleotide-based array CGH revealed an ap-
proximately 1.1 Mb deletion at 19p13.3 (chr19:213,080-
1,322,552, UCSC hg 18 in the patient). Normal FISH and
BAC-based array results in her parents pointed to this dele-
tion as being de novo. Furthermore, the patient also pre-
sented 760 kb duplication at 3q29
(chr3:197,254,006-198,014,826). As BAC-based
microarray analysis of the parents showed the mother as
carrying this same duplication, this was considered as ma-
ternal in origin.
The ~1.1 Mb deletion in our patient encompassed at
least 47 genes: PPAP2C, MIER2, THEG, C2CD4C, SHC2
ODF3L2,, MADCAM1, C19orf20, CDC34, GZMM, BSG,
HCN2, POLRMT, FGF22, FSTL3, RNF126, PRSSL1,
PALM, C19orf21, PTBP1, LPPR3, AZU1, PRTN3,
ELANE, CFD, MED16, C19orf22, KISS1R, ARID3A,
WDR18, GRIN3B, C19orf6, CNN2, ABCA7, HMHA1,
POLR2E, GPX4, SBNO2, STK11, C19orf26, ATP5D,
MIDN, C19orf23, CIRBP, C19orf24, EFNA2, and MUM1
(Figure 2).
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Figure 1 - Patient at 14 years of age. A and B - Facial appearance. Note the epicanthic folds, high nasal bridge and black pigment spots on the eyelids,
nose, cheeks and lips. C - Note the wide gap between the first and second toes.The girl, although here described as the third patient
reported with a larger than 1 Mb deletion at 19p13.3, is the
first presenting a PJS phenotype and other atypical clinical
manifestations in association with this deletion. The two-
months-old patient reported by Hurgoiu and Suciu (1984),
presented, through ocular findings, primitive vitreous body
and punched-out lesions of the retina. Besides being deaf,
spastic, microcephalic and anemic, there were epicanthic
folds and umbilical hernia. By karyotyping, his deletion
was defined as 19p13-pter, with no further molecular char-
acterization, thus thwarting a clear comparison with the de-
letion in our patient.
The male patient described by Archer et al. (2005)
presented unusual facial appearance, cleft palate, mixed
sensorineural and conductive deafness, a congenital heart
defect, keloid scaring, immune dysfunction, seizures and
moderate learning difficulties. His ~1.2 Mb deletion in-
volved approximately 60 genes. After FISH, a BAC clone
containing STK11 gene was found to be partially deleted,
thus impeding gene-status definition. Features shared with
our patient were a congenital heart defect and learning dif-
ficulties. The aforementioned congenital heart defect was
characterized by pulmonary stenosis with dysplastic
tricuspid valve, a ventricular septal defect (VSD) and mild
over-ride of the aorta. Two of his five siblings, although
withoutthe19p13.3deletion,alsoborecongenitalheartde-
fects,ascoarctationoftheaorta,bicuspidaorticvalveanda
VSD in one, and an atrioseptal defect in the other. Notwith-
standing, the authors suggested that the cardiac defect in
their patient was more likely related to deletion of the
19p13.3 chromosome, than to a family-trait.
Some of the genes mapped to the deleted segment,
bothinourpatientandthatofArcheretal.(2005),mightbe
relatedtocardiacanomalies.CNN2(calponin2)codesfora
protein that is involved in smooth-muscle contraction.
Shown to be expressed in mouse embryonic and adult
hearts (Masuda et al., 1996), it appears to be co-localized
with vinculin in the cell-to-cell junctions of
cardiomyocytes. SHC2 (SHC transforming protein 2), be-
sides encoding a member of the SHC family of cell signal-
ing proteins, interacts with the vascular endothelial growth
factor(VEGF)(Ratcliffeetal.,2002).TheVEGFsignaling
system plays a critical role in heart formation (Vannay et
al., 2006; Zhao et al, 2010). FSTL3 (follistatin like 3), a de-
velopmental gene coding for a member of the follistatin-
module protein family, is composed of extracellular ma-
trix-associated glycoproteins. It acts by binding morpho-
genesis or growth and differentiation factors, as well as
regulating their activity during development (Arai et al.,
2003). FSTL, abundantly expressed in fetal and adult
mouse hearts, neutralizes several transforming growth fac-
tor-beta (TGF-beta) superfamily members, this including
myostatin (Takehara-Kasamatsu et al., 2007). FSTL3 also
binds both activin and BMP2 (Tsuchida et al., 2000). A
hypomorphic BMP2 (bone morphogenetic protein 2) re-
ceptor has been associated with congenital heart defects in
murine models (Delot et al., 2003). Recently BMP2-
induced kinase was associated with the high level myopia
(Liu et al., 2009) present in our patient. Therefore, haplo-
insufficiencyofFSTL3maycontributetobothheartdefects
and ocular anomalies.
Another gene, possibly related to cardiac malforma-
tion, is PTBP1 (polypyrimidine tract binding protein 1).
This belongs to a subfamily of ubiquitously expressed het-
erogeneous nuclear ribonucleoproteins, RNA-binding pro-
teins that appear to influence mRNA processing. Zhang et
al. (2009) showed that PTB, besides contributing to apop-
totic gene expression, also modulates susceptibility to
caspase activation by differentiating rat cardiomyocytes.
Cardiac morphologic abnormalities were also found in
mice deficient in key regulators of caspase-dependent sig-
naling.
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Figure 2 - Deletion at 19p13.3. Array-CGH analysis showed a single-copy loss of 84 oligonucleotide probes at 19p13.3, approximately 1.1 Mb in size
(chr19:213,080-1,322,552, UCSC March 2006 hg18 assembly). Genes encompassed by the deletion are listed.(DECIPHER) lists large 19p13.3 deletion cases. Pheno-
types were not reported in a patient with an 0.72 Mb de
novo deletion and another with an 0.89 Mb, whose parents
had not been analyzed. Another patient with an atrial sep-
tum defect and intellectual disability, besides bearing an
0.58 Mb deletion at 19p13.3 which did not encompass
STK11,alsocarried2Mbduplicationat16q24.Parentshad
also not been analyzed.
Le Meur et al. (2004) reported a PJS patient with
learning disabilities, scoliosis and paternally inherited type
1neurofibromatosis(NF1).His250kbdeletionat19p13.3,
including STK11, was inherited from his mother, also diag-
nosed as PJS. The concomitant presence of NF1 makes it
difficult to attribute learning disability to 19p13.3 deletion.
This deletion also removed GRIN3B, CNN2, ABCA7,
HMHA1, POLR2E, GPX4 and SBNO2 genes.
The PJS features in our patient can be attributed to
haploinsufficiency for STK11. STK11 haploinsufficiency
could not be proved in the patient with a deletion at
19p13.3, but without PJS features, as reported by Archer et
al. (2005). Whereas, it was proposed that this patient might
have a milder and undiagnosed disease or that haploin-
sufficiency for STK11 might not cause PJS, in the very
same year, Aretz et al. (2005) reported that approximately
30% of the patients with PJS presented partial or complete
STK11 deletion, and STK11 haploinsufficiency was con-
firmed as a cause for PJS in other patients (Hearle et al.,
2006; Resta et al., 2010; Volikos et al., 2006).
Resta et al. (2010), on evaluating 51 patients with
PJS, found 15 STK11 deletions ranging from 2.9 to 180 kb,
six of which including additional genes. As these patients
presented classical PJS features, but no further anomalies,
they proposed that haploinsufficiency of the contiguous
genes SBNO2, C19orf26, ATP5D, MIDN, C19orf23,
CIRBP, C19orf24 and EFNA2 did not impact the pheno-
type. These genes, also deleted in our patient, should not be
considered as candidates for her atypical clinical features.
In addition to the 19p13.3 deletion, our patient
showed a maternally inherited 760 kb duplication at 3q29,
encompassing 10 genes. Most probably it is a copy number
variation without overt clinical impact, as this was also
present in her phenotypically normal mother.
In conclusion we describe a patient with PJS and
other clinical findings associated with a deletion at
19p13.3. This case illustrates the need of screening for
large deletions those patients who present PJS together
with atypical clinical features.
References
Arai KY, Tsuchida K, Uehara K, Taya K and Sugino H (2003)
Characterization of rat follistatin-related gene: Effects of
estrouscyclestageandpregnancyonitsmessengerRNAex-
pression in rat reproductive tissues. Biol Reprod 68:199-
206.
Archer HL, Gupta S, Enoch S, Thompson P, Rowbottom A, Chua
I, Warren S, Johnson D, Ledbetter DH, Lese-Martin C, et al.
(2005) Distinct phenotype associated with a cryptic sub-
telomeric deletion of 19p13.3-pter. Am J Med Genet A
136:38-44.
Aretz S, Stienen D, Uhlhaas S, Loff S, Back W, Pagenstecher C,
McLeod DR, Graham GE, Mangold E, Santer R, et al.
(2005) High proportion of large genomic STK11 deletions
in Peutz-Jeghers syndrome. Hum Mutat 26:513-519.
Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH,
Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF,
Friedrich CA, et al. (2008) Expanding the clinical pheno-
type of the 3q29 microdeletion syndrome and characteriza-
tionofthereciprocalmicroduplication.MolCytogenet1:e8.
Delot EC, Bahamonde ME, Zhao M and Lyons KM (2003) BMP
signaling is required for septation of the outflow tract of the
mammalian heart. Development 130:209-220.
Duker AL, Ballif BC, Bawle EV, Person RE, Mahadevan S,
Alliman S, Thompson R, Traylor R, Bejjani BA, Shaffer
LG, et al. (2010) Paternally inherited microdeletion at
15q11.2 confirms a significant role for the SNORD116 C/D
box snoRNA cluster in Prader-Willi syndrome. Eur J Hum
Genet 18:1196-1201.
Forcet C, Etienne-Manneville S, Gaude H, Fournier L, Debilly S,
Salmi M, Baas A, Olschwang S, Clevers H and Billaud M
(2005) Functional analysis of Peutz-Jeghers mutations re-
veals that the LKB1 C-terminal region exerts a crucial role
in regulating both the AMPK pathway and the cell polarity.
Hum Mol Genet 14:1283-1292.
Giardiello FM and Trimbath JD (2006) Peutz-Jeghers syndrome
and management recommendations. Clin Gastroenterol
Hepatol 4:408-415.
Hearle NC, Rudd MF, Lim W, Murday V, Lim AG, Phillips RK,
Lee PW, O’Donohue J, Morrison PJ, Norman A, et al.
(2006) Exonic STK11 deletions are not a rare cause of
Peutz-Jeghers syndrome. J Med Genet 43:e15.
Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S,
LoukolaA,BignellG,WarrenW,AminoffM,HoglundP,et
al. (1998) A serine/threonine kinase gene defective in
Peutz-Jeghers syndrome. Nature 391:184-187.
Hurgoiu V and Suciu S (1984) Occurrence of 19p- in an infant
with multiple dysmorphic features. Ann Genet 27:56-57.
JenneDE,ReimannH,NezuJ,FriedelW,LoffS,JeschkeR,Mul-
ler O, Back W and Zimmer M (1998) Peutz-Jeghers syn-
drome is caused by mutations in a novel serine threonine
kinase. Nat Genet 18:38-43.
Le Meur N, Martin C, Saugier-Veber P, Joly G, Lemoine F,
Moirot H, Rossi A, Bachy B, Cabot A, Joly P, et al. (2004)
Complete germline deletion of the STK11 gene in a family
with Peutz-Jeghers syndrome. Eur J Hum Genet 12:415-
418.
LiuHP,LinYJ,LinWY,WanL,SheuJJ,LinHJ,TsaiY,TsaiCH
and Tsai FJ (2009) A novel genetic variant of BMP2K con-
tributes to high myopia. J Clin Lab Anal 23:362-367.
Masuda H, Tanaka K, Takagi M, Ohgami K, Sakamaki T, Shibata
NandTakahashiK(1996)Molecularcloningandcharacter-
ization of human non-smooth muscle calponin. J Biochem
120:415-424.
Ratcliffe KE, Tao Q, Yavuz B, Stoletov KV, Spring SC and
Terman BI (2002) Sck is expressed in endothelial cells and
560 Souza et al.participates in vascular endothelial growth factor-induced
signaling. Oncogene 21:6307-6316.
Resta N, Giorda R, Bagnulo R, Beri S, Mina ED, Stella A,
Piglionica M, Susca FC, Guanti G, Zuffardi O, et al. (2010)
Breakpoint determination of 15 large deletions in Peutz-
Jeghers subjects. Hum Genet 28:373-382.
Takehara-Kasamatsu Y, Tsuchida K, Nakatani M, Murakami T,
Kurisaki A, Hashimoto O, Ohuchi H, Kurose H, Mori K,
Kagami S, et al. (2007) Characterization of follistatin-
related gene as a negative regulatory factor for activin fam-
ily members during mouse heart development. J Med Invest
54:276-288.
TraylorRN,FanZ,HudsonB,RosenfeldJA,ShafferLG,Torchia
BS and Ballif BC (2009) Microdeletion of 6q16.1 encom-
passingEPHA7inachildwithmildneurologicalabnormali-
ties and dysmorphic features: Case report. Mol Cytogenet
2:17.
Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y
and Sugino H (2000) Identification and characterization of a
novel follistatin-like protein as a binding protein for the
TGF-beta family. J Biol Chem 275:40788-40796.
Vannay A, Vasarhelyi B, Kornyei M, Treszl A, Kozma G, Gyorf-
fy B, Tulassay T and Sulyok E (2006) Single-nucleotide
polymorphisms of VEGF gene are associated with risk of
congenital valvuloseptal heart defects. Am Heart J
151:878-881.
Volikos E, Robinson J, Aittomaki K, Mecklin JP, Jarvinen H,
Westerman AM, de Rooji FW, Vogel T, Moeslein G, Lau-
nonen V, et al. (2006) LKB1 exonic and whole gene dele-
tionsareacommoncauseofPeutz-Jegherssyndrome.JMed
Genet 43:e18.
Zhang J, Bahi N, Llovera M, Comella JX and Sanchis D (2009)
Polypyrimidinetractbindingproteins(PTB)regulatetheex-
pression of apoptotic genes and susceptibility to caspase-
dependent apoptosis in differentiating cardiomyocytes. Cell
Death Differ 16:1460-1468.
Zhao W, Wang J, Shen J, Sun K, Zhu J, Yu T, Ji W, Chen Y, Fu Q
and Li F (2010) Mutations in VEGFA are associated with
congenital left ventricular outflow tract obstruction. Bio-
chem Biophys Res Commun 396:483-488.
Internet Resources
DECIPHER, DatabasE of Chromosomal Imbalance and Pheno-
type in Humans using Ensemble Resources, http://deci-
pher.sanger.ac.uk (June 30, 2011).
Associate Editor: Angela M. Vianna-Morgante
License information: This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
19p13.3 deletion 561